These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2508108)

  • 1. Platelet activation and cyclo-and lipoxygenase-activities in diabetes type II.
    Rösen P; Tschöpe D; Kayser S; Kaufmann L
    Prog Clin Biol Res; 1989; 301():359-63. PubMed ID: 2508108
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme immunoassays for cyclooxygenase and 12-lipoxygenase of human platelets.
    Yoshimoto T; Ehara H; Konishi Y; Yokoyama C; Murakami J; Yamamoto S; Hattori A
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():82-5. PubMed ID: 2526567
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modulation of platelet tyrosine phosphatases by arachidonic acid metabolites in diabetes mellitus complicated with acute pyogenic inflammation].
    Barinova ME
    Patol Fiziol Eksp Ter; 2010; (2):23-6. PubMed ID: 20804071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormal arachidonate metabolites in diabetes mellitus].
    Asano M; Okuda Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():705-10. PubMed ID: 9392185
    [No Abstract]   [Full Text] [Related]  

  • 5. Normal platelet function, but increased platelet activation in vivo in diabetic patients.
    Tomaselli L; Cerletti C; de Gaetano G; Notarbartolo A; Davì G; Pupillo M
    Thromb Haemost; 1990 Dec; 64(4):604. PubMed ID: 2128141
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Thromb Haemost; 1984 Jul; 51(3):313-6. PubMed ID: 6495252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane and 6-oxo-PGF1 alpha in the plasma of patients with diabetes type I and II.
    Rösen P; Hohl C; Tschöpe D; Körner A; Halfmann U; Berger M
    Prog Clin Biol Res; 1987; 242():247-52. PubMed ID: 3671386
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase and lipoxygenase activities of platelet-depleted human monocytes.
    Pawlowski NA; Abraham E; Hamill A; Scott WA
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):324-30. PubMed ID: 6432875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
    Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of arachidonic acid metabolites to atherosclerosis.
    Dembińska-Kieć A; Gryglewski RJ
    Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA; Nedogoda VV; Konan K
    Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of substance P on the arachidonate cascade of rat platelets.
    Kis B; Mezei Z; Gecse A; Telegdy G
    Acta Physiol Hung; 1997-1998; 85(2):89-97. PubMed ID: 9706302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second messenger function of phosphatidic acid in platelet activation.
    Kroll MH; Zavoico GB; Schafer AI
    J Cell Physiol; 1989 Jun; 139(3):558-64. PubMed ID: 2738101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
    Cerletti C
    Int J Tissue React; 1985; 7(4):309-12. PubMed ID: 3934097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitors of platelet arachidonic acid metabolism: aggregation independent of lipoxygenase.
    Sams AR; Sprecher H; Sankarappa SK; Needleman P
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():19-28. PubMed ID: 6211951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.